Posters, Tuesday, 7 May 2002 zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONML
209s
P53. Sleep disorders
P53.03
P53.01
Circammal
symptoms
Sleep quality in schizophrenic
A. Schreiner
l
Janssen-Cilag
patients taking antipsychotics
Antipsychotic
drugs affect sleep regulation during treatment and
following withdrawal. Available data are reviewed.
Typical antipsychotics
improve sleep efficiency and increase
REM latency without changing the duration of sleep stages. Atypical antipsychotics exert varying effects on sleep due to differences
in central receptor interactions. Open treatment with olanzapine
reduced stage 1 sleep, and increased stage 2 sleep, delta sleep
and REM density. Clozapine increased stage 2 sleep, reduced
stage 1 sleep and lengthened REM latency. Improved sleep maintenance and an association between positive clinical results and
prolonged stage 2 sleep were reported. Risperidone significantly
improved subjective and objective sleep quality in young and
elderly schizophrenics.
Additionally, schizophrenics
treated with
risperidone appear to have significantly better night-time sleep
quality and daytime functioning.
Conclusion: Atypical antipsychotics
have shown superior efficacy on sleep profile compared to conventional neuroleptics.
Atypicals demonstrate beneficial effects on multiple aspects of
sleep patterns, with most data being available for risperidone. The
clinical utility of antipsychotics
with favourable effects on sleep
may extend to sleep-related problems in other patient groups, such
as night-wandering
in elderly patients with dementia.
and psychiatric
0bjective:To study the circammal variation of sleep disturbances
as a function of psychiatric symptom burden
Method: The circammal variation in self-reported sleep from
a general health survey of all inhabitants in a Norwegian county
(70 000 people, HUNT II) were analysed with respect to burden
of depressive and anxious symptoms, as well as family history of
psychiatric disturbances.
Results: Circannual variation was evident in all sleep related
variables, but most pronounced for time spent in bed. Individuals with high levels of anxiety or depression had higher levels
of sleep disturbances,
and an accentuated circannual variation.
Asymptomatic
individuals with a family history of psychiatric
disorder had higher levels of sleep disturbance than the general
population, but the circarmual variation of the disturbances did not
differ from the general population.
Conclusions:
There was a circannual variation in all sleep
variables. Individuals with high levels of anxiety and depression
had a more pronounced circannual variation. This was not observed
in asymptomatic individuals with a family history of psychiatric
disorders.
P53.04
Sleep complaints predict coronary artery disease mortality in
males: a twelve-year follow-up study of a middle-aged Swedish
population
P53.02
Sleep deprivation
of sleep disturbances
D. Neckehnamr’ *, A. Myklettm3, A.A. Dahl. ‘Hat&land Uniuersiv Hospital; 2 University of Bergen; 4 University of Oslo, Norway
GmbH, Germany
effects on subjective sleep clomplaints
F. Cavaglia’, D. Pires-Barreira,
L. Paula, A. Matos-Pires,
riaga. FML. ISCS-Sul, Lisbon, Portugal
variation
F. Ar-
Objectives: Already knowing the existence of an association between acute sleep deprivation and subjective sleep complaints we
tried to clarify this issue.
Methods: Twelve healthy volunteers were selected taking into
account predetined exclusion criteria. A crossover design was
utilised in which each healthy subject provided data related to
the wake period after being exposed to two different experimental
conditions: a “normal” sleep period (23:00 to 07:OO) and a deprived
sleep period (03:OO to 07:OO). To avoid a carryover effect between
the first evaluation and the second one an interval of seven days
was imposed. The following subjective evaluations were applied:
Epworth Sleepiness Scale (ESS), Oswald and Norris visual analogue scales. The Wilcoxon test was employed to compare data.
Results: Sleep quality (Oswald scale) was worse after a deprived
sleep period (Z=-1.97; p=O.O48). Two Norris Scales discriminated
the two conditions, favouring the non-deprived sleep period (Norris
12: Z=-2.60; t~O.009) - (Norris 17: Z=-1.98: .u=O.O48). Davtime
sleepiness was significantly higher after a deprived sleep period
(ESS total score; Z=-2.25; p=O.O24).
Conclusions: Accordingly
with our findings it seems to be
untrue that sleep deprived healthy subjects could ever be “activated”
with acute sleep deprivation.
L. Mallon’, J. Hetta, J.-E. Broman. Department of Neuroscience
Psychiatry, Uppsala University Hospital, Sweden
-
This study was conducted to determine whether sleep complaints
in a middle-aged population predicted total mortality and CAD
mortality. In 1983, a random sample of 1,870 subjects aged 4565 years in The County of Dalama in Sweden responded to a
postal questionnaire
(response rate 70.2%) including questions
about sleep complaints and various diseases. Mortality data for
the period 1983-1995 were collected, and Cox proportional hazard
analyses were used to examine the mortality risks.
At twelve-year follow-up 165 males (18.2%) and 101 females
(10.5%) had died. After adjustment for a wide range of important
putative risk factors, difficulties initiating sleep (DIS) were related
to CAD death in males (relative risk [RR], 3.1; 95% confidence
interval [CI], 1.5-6.3; p<O.Ol), but not in females. Short or long
sleep duration did not influence risk of CAD mortality or total
mortality for either gender. Depression in males increased the risk
of death attributed to CAD (RR, 3.0; 95% CI, 1.1-8.4; ~~0.05) and
total mortality (RR, 2.2; 95% CI, 1.14.5; pcO.05). These results
provide evidence that there is an association between difficulties
falling asleep and CAD mortality in males.
P53.05
Features and correlates
of insomnia in medical in-patients
M. Spiliotis l, M. Liarou, T. Tsouti, E. Ibanda, N. Polonifis, J. Kogeorgos. Psychiatric Department, Konstantopoulio Gene& Hospital
‘iighia Olga “, Athens, Greece
Introduction: Insomnia, is particularly common among medical
in-patients, relating to several interacting factors, not least the
pathological process of the illness and medication. In these patients,